Cargando…
In silico docking and ADME study of deketene curcumin derivatives (DKC) as an aromatase inhibitor or antagonist to the estrogen-alpha positive receptor (Erα(+)): potent application of breast cancer
Regardless of many extensive studies, hormonal-based breast cancer is the most common cause of cancer-related mortality of females worldwide. Indeed, estrogen receptor-positive (ER +) is the communal subtype in breast cancer. To treat this, three types of medications are typically used: selective es...
Autores principales: | Shah, Vraj, Bhaliya, Jaydip, Patel, Gautam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794617/ https://www.ncbi.nlm.nih.gov/pubmed/35106036 http://dx.doi.org/10.1007/s11224-021-01871-2 |
Ejemplares similares
-
Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose
por: MaruYama, Takashi, et al.
Publicado: (2023) -
Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents
por: Michalak, Olga, et al.
Publicado: (2023) -
Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011) -
DKC1 overexpression associated with prostate cancer progression
por: Sieron, P, et al.
Publicado: (2009) -
Novel huperzine A based NMDA antagonists: insights from molecular docking, ADME/T and molecular dynamics simulation studies
por: Sigalapalli, Dilep Kumar, et al.
Publicado: (2020)